# FDA Inspection 1276213 - Beltapharm SPA - July 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/beltapharm-spa/f2460960-13c5-42e9-9bca-ba33b432e2d1
Source feed: FDA_Inspections

> FDA Inspection 1276213 for Beltapharm SPA on July 14, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276213
- Company Name: Beltapharm SPA
- Inspection Date: 2023-07-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1131397 - 2019-03-29](https://www.keypedia.com/records/fda_inspections/beltapharm-spa/349958d7-d4dc-46bb-a1c4-2bd843b3a02a)
- [FDA Inspection 931052 - 2015-05-15](https://www.keypedia.com/records/fda_inspections/beltapharm-spa/337d7a3e-2d98-4a2b-9fb3-a02eb47e1c71)
- [FDA Inspection 839721 - 2013-06-14](https://www.keypedia.com/records/fda_inspections/beltapharm-spa/90e0f960-f00b-4316-8d95-c5a2dc97e96b)

Company: https://www.keypedia.com/companies/beltapharm-spa/065f1660-d797-445e-bd30-8e67eedd2390

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c